MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Improving clinical data collection at patients’ home in Parkinson’s disease: The Sleep Fit app

    A. Mascheroni, C. Ferlito, S. Hackethal, S. Caverzasio, E-K. Choe, Y. Luo, F. Faraci, A. Kaelin-Lang, A. Puiatti, P-L. Ratti, M. Marazza (Manno, Switzerland)

    Objective: We introduce Sleep Fit, the first tablet application to collect subjective and objective clinical data especially designed for patients with Parkinson’s Disease (PD). Background:…
  • 2018 International Congress

    The Levodopa Response Trial and the Parkinson Disease Digital Biomarker Challenge: Monitoring symptoms of Parkinson’s disease in the lab and home using wearable sensors

    J. Daneault, G. Vergara-Diaz, G. Costante, E. Fabara, G. Ferreira-Carvalho, F. Golabchi, F. Parisi, S. Sapienza, Y. Chae, P. Snyder, P. Aubin, P. Banda, D. Brunner, R. Dorsey, L. Mangravite, W. Marks, E. Neto, U. Rubin, E. Soderberg, D. Daeschler, S. Moore, S. Sieberts, L. Omberg, P. Bonato, The Parkinson's Disease Digital Biomarker DREAM Challenge Consortium (Newark, NJ, USA)

    Objective: To leverage a community of researchers and shared wearable data to develop algorithms to estimate the severity of PD specific symptoms. Background: People with…
  • 2018 International Congress

    A study on pre-adoption of a self-management application by Parkinson’s disease patients

    M. Memedi, J. Lindqvist, T. Tunedal, A. Duvåker (Örebro, Sweden)

    Objective: The aim of this paper is to investigate factors influencing acceptance by Parkinson's disease (PD) patients of a self-management application for an Internet of…
  • 2018 International Congress

    Turkish version quality of life in essential tremor questionnaire (quest): Validity and reliability study

    S. Güler, N. Turan (Edirne, Turkey)

    Objective: Our aim was to translate the Quality of Life in Essential Tremor Questionnaire (QUEST) advanced by Troster (2005) and to analyse the validity and…
  • 2018 International Congress

    Fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor subjects demonstrate distinct tremor characteristics using quantitative tremorography

    E. Robertson, D. Hall, G. Pal, B. Ouyang, Y. Liu, A. McAsey, A. Bery, C. Huml, B. Bernard, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)

    Objective: To compare Fragile X-associated tremor/ataxia syndrome (FXTAS), Parkinson disease (PD), essential tremor (ET) and controls using quantitative measures of tremor. Background: FXTAS, a progressive…
  • 2018 International Congress

    Alternating thalamic deep brain stimulation for Essential Tremor: A trial to reduce habituation

    M. Seier, A. Hiller, J. Quinn, C. Murchison, M. Brodsky, S. Anderson (Omaha, NE, USA)

    Objective: We propose a novel approach to the treatment paradigm for deep brain stimulation (DBS) programming in the ventral intermediate nucleus (VIM) for patients with…
  • 2018 International Congress

    Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

    H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…
  • 2018 International Congress

    Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    The development of an instrument for measuring Parkinson’s patient empowerment

    P. Viwattanakulvanid (Bangkok, Thailand)

    Objective: To develop a valid and reliable measurement scale of Parkinson’s patient empowerment index (PPEI). Background: Patient empowerment concept has been used as part of…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 177
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley